283 research outputs found

    Gastrointestinal stromal tumors with pseudocystic change mimicking a pancreatic tumor: two case reports

    Get PDF
    <p>Abstract</p> <p>Introduction</p> <p>Cystic lesions of the upper abdomen normally develop from pancreatic tissue. The differential diagnoses include neoplastic and non-neoplastic lesions. Pseudocystic tumors that secondarily involve the pancreas are very rare and may lead to diagnostic pitfalls.</p> <p>Case presentation</p> <p>A 51-year-old woman and a 65-year-old man, both German, presented with abdominal cystic lesions suspected to be pancreatic pseudocysts. Both tumors were classified as gastrointestinal stromal tumors, epithelioid subtype. In one case, tumor origin in the gastric wall was confirmed by relaparotomy. In the other case, a point mutation in <it>PDGFRalpha</it> gene, exon 18 proved the diagnosis of gastrointestinal stromal tumor. The tumors were resected and both patients are still alive and disease-free.</p> <p>Conclusions</p> <p>The differential diagnosis of cystic lesions in the upper abdomen must include gastrointestinal stromal tumors with pseudocystic change. The origin of a large cystic gastrointestinal stromal tumor may be difficult to determine. Epithelioid tumor pattern, weak or absent KIT expression and detection of <it>PDGFRalpha</it> mutation are typical diagnostic parameters of gastric gastrointestinal stromal tumors.</p

    Teachers\u27 and school administrators\u27 view on extended responsibility. An study on "school profiles" in bavarian schools

    Full text link
    Bei einer Befragung von Schulleitungen und LehrkrĂ€ften an Hauptschulen, Realschulen und Gymnasien zeigt sich, dass die Entwicklung eines Schulprofils fĂŒr wichtig gehalten wird und mit hohen Erwartungen verbunden ist. Allerdings ergeben sich im Hinblick auf spezifische Einzelaspekte und im Vergleich der Schularten durchaus unterschiedliche Befunde, die in der weiteren Diskussion zu berĂŒcksichtigen sind. Insgesamt ergibt sich aus dem Zusammenhang von WertschĂ€tzung eines Schulprofils, hohen Erwartungen an schulische Autonomie und starker Betonung sozialer Beziehungen sowie der OrganisationsqualitĂ€t von Schule innerhalb der Lehrerschaft und bei den Schulleitungen ein vergleichsweise gĂŒnstiges "Stimmungsbild" fĂŒr die Schulentwicklung. (DIPF/Orig.)Interviews of teachers and school admistrators of different school types have shown that the development of a school profile is taken to be important and is connected to high expectations. However, findings vary in regard to specific single aspects and in comparison to the various types of school and these have to be taken into consideration in future discussions. (DIPF/Orig.

    Primary NK/T cell lymphoma nasal type of the stomach with skin involvement: a case report

    Get PDF
    Since nasal NK/T cell lymphoma and NK/T cell lymphoma nasal type are rare diseases, gastric involvement has seldom been seen. We report a unique case of a patient with a primary NK/T cell lymphoma nasal type of the stomach with skin involvement. The patient had no history of malignant diseases and was diagnosed with hematemesis and intense bleeding from his gastric primary site. Shortly after this event, exanthemic skin lesions appeared with concordant histology to the primary site. Despite chemotherapy, the patient died one month after the first symptomatic appearance of disease

    Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible

    Get PDF
    Multiple myeloma (MM) is a heterogeneous disease with survival ranging from months to decades. The goal of ‘cure’ remains elusive for most patients, but has been shown to be possible, with durable remission and a transition to a plateau phase (analogous to monoclonal gammopathy of uncertain significance/smoldering Myeloma (MGUS/SMM)). Two representative cases set the stage to illustrate how this might be possible and what still needs to be determined to achieve functional disease control over a prolonged period. Several developments have emerged, such as improved diagnostics including the definitions and use of SLiM-CRAB criteria and MRD with whole genome- /single-cell-sequencing as well as other correlates to better understand disease biology. These advances enable earlier detection, more accurate risk stratification and improved personalized treatment strategies by facilitating analysis of genetic alterations and clonal heterogeneity. Whole genome sequencing may also identify driver mutations and modes of resistance to targets like immunotherapies (IOs) as well as other targeted therapies. Today, induction with a CD38 antibody (CD38mAb), proteasome inhibitor, immunomodulatory drug, and dexamethasone, potentially followed by ASCT and lenalidomide maintenance, can be considered standard of care for transplant-eligible (TE) newly diagnosed (NDMM) patients. Whether prolonged disease control and functional cure can be achieved in non-transplant eligible (NTE) patients is currently emerging as a distinct possibility: data from phase III trials that incorporate a CD38mAb into the treatment of NTE NDMM patients demonstrate impressive MRD negativity rates that appear sustained over several years. While the long-term durability of CAR-Ts, bi-specific antibodies and other IOs are evaluated, several clinical trials are now investigating their role in frontline treatment for TE and NTE patients. These will address whether CAR-Ts will replace ASCT and whether such IOs will represent a truly curative option. We conclude that whilst cure remains elusive, the concept of operational or functional cure provides a new benchmark to strive for and is an emerging area of active and potentially achievable clinical research for MM

    Subglottic MALT Lymphoma of the Larynx - More Attention to the Glottis

    Get PDF
    Abstract. Background: Mucosa-associated Since the first description of lymphoma arising from mucosaassociated lymphoid tissue (MALT) as an entity by Isaacson and Wright in 1983 (1), several cases of laryngeal MALT were reported in a more or less anecdotal form, starting with Diebold and colleagues in 1990 (2). The case reported by Case Report A 62-year-old male with adipositas was admitted and complained of a dry cough, increasing exertional dyspnea, and stridor for one year. Blood work and clinical examination were uneventful. In order to prevent edema due to mechanical manipulation, 250 mg cortisone were administered intravenously one hour prior to flexible bronchoscopy. The bronchoscopy revealed a circumferential subglottic lesio

    Interleukin-9 (IL-9) and NPM-ALK each generate mast cell hyperplasia as single ‘hit’ and cooperate in producing a mastocytosis-like disease in mice

    Get PDF
    Mast cell neoplasms are characterized by abnormal growth and focal accumulation of mast cells (MC) in one or more organs. Although several cytokines, including stem cell factor (SCF) and interleukin-9 (IL-9) have been implicated in growth of normal MC, little is known about pro-oncogenic molecules and conditions triggering differentiation and growth of MC far enough to lead to the histopathological picture of overt mastocytosis. The anaplastic lymphoma kinase (ALK) has recently been implicated in growth of neoplastic cells in malignant lymphomas. Here, we describe that transplantation of NPM-ALK-transplanted mouse bone marrow progenitors into lethally irradiated IL-9 transgenic mice not only results in lymphoma-formation, but also in the development of a neoplastic disease exhibiting histopathological features of systemic mastocytosis, including multifocal dense MC-infiltrates, occasionally with devastating growth in visceral organs. Transplantation of NPM-ALK-transduced progenitors into normal mice or maintaintence of IL-9-transgenic mice without NPM-ALK each resulted in MC hyperplasia, but not in mastocytosis. Neoplastic MC in mice not only displayed IL-9, but also the IL-9 receptor, and the same was found to hold true for human neoplastic MC. Together, our data show that neoplastic MC express IL-9 rececptors, that IL-9 and NPM-ALK upregulate MC-production in vivo, and that both ‘hits’ act in concert to induce a mastocytosis-like disease in mice. These data may have pathogenetic and clinical implications and fit well with the observation that neoplastic MC in advanced SM strongly express NPM and multiple “lymphoid” antigens including CD25 and CD30

    Analyzing Longitudinal wb-MRI Data and Clinical Course in a Cohort of Former Smoldering Multiple Myeloma Patients: Connections between MRI Findings and Clinical Progression Patterns

    Full text link
    The purpose of this study was to analyze size and growth dynamics of focal lesions (FL) as well as to quantify diffuse infiltration (DI) in untreated smoldering multiple myeloma (SMM) patients and correlate those MRI features with timepoint and cause of progression. We investigated 199 whole-body magnetic resonance imaging (wb-MRI) scans originating from longitudinal imaging of 60 SMM patients and 39 computed tomography (CT) scans for corresponding osteolytic lesions (OL) in 17 patients. All FLs >5 mm were manually segmented to quantify volume and growth dynamics, and DI was scored, rating four compartments separately in T1- and fat-saturated T2-weighted images. The majority of patients with at least two FLs showed substantial spatial heterogeneity in growth dynamics. The volume of the largest FL (p = 0.001, c-index 0.72), the speed of growth of the fastest growing FL (p = 0.003, c-index 0.75), the DI score (DIS, p = 0.014, c-index 0.67), and its dynamic over time (DIS dynamic, p < 0.001, c-index 0.67) all significantly correlated with the time to progression. Size and growth dynamics of FLs correlated significantly with presence/appearance of OL in CT within 2 years after the respective MRI assessment (p = 0.016 and p = 0.022). DIS correlated with decrease of hemoglobin (p < 0.001). In conclusion, size and growth dynamics of FLs correlate with prognosis and local bone destruction. Connections between MRI findings and progression patterns (fast growing FL—OL; DIS—hemoglobin decrease) might enable more precise diagnostic and therapeutic approaches for SMM patients in the future
    • 

    corecore